DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,095,544 | +3.4% | 12,477 | 0.0% | 0.35% | +7.1% |
| Q2 2023 | $2,994,480 | -4.8% | 12,477 | 0.0% | 0.33% | -6.1% |
| Q1 2023 | $3,144,703 | -5.8% | 12,477 | -0.8% | 0.35% | -8.0% |
| Q4 2022 | $3,338,187 | +1.0% | 12,577 | -1.7% | 0.38% | -8.3% |
| Q3 2022 | $3,304,000 | +1.1% | 12,792 | -0.8% | 0.41% | +9.6% |
| Q2 2022 | $3,268,000 | -17.8% | 12,892 | -4.9% | 0.38% | -10.3% |
| Q1 2022 | $3,978,000 | -10.8% | 13,562 | 0.0% | 0.42% | -7.9% |
| Q4 2021 | $4,462,000 | +3.2% | 13,562 | -4.5% | 0.45% | -2.8% |
| Q3 2021 | $4,322,000 | +12.7% | 14,197 | -0.7% | 0.47% | +17.9% |
| Q2 2021 | $3,835,000 | +14.3% | 14,292 | -4.1% | 0.40% | +3.7% |
| Q1 2021 | $3,354,000 | +1.5% | 14,902 | -0.2% | 0.38% | -10.3% |
| Q4 2020 | $3,306,000 | +2.6% | 14,927 | -0.3% | 0.43% | -12.7% |
| Q3 2020 | $3,223,000 | +21.8% | 14,970 | 0.0% | 0.49% | +19.9% |
| Q2 2020 | $2,647,000 | -4.2% | 14,970 | -25.0% | 0.41% | -16.4% |
| Q1 2020 | $2,764,000 | -9.8% | 19,970 | 0.0% | 0.49% | +16.0% |
| Q4 2019 | $3,065,000 | -11.5% | 19,970 | -16.7% | 0.42% | -14.6% |
| Q3 2019 | $3,462,000 | +1.1% | 23,970 | 0.0% | 0.49% | +3.6% |
| Q2 2019 | $3,426,000 | +7.4% | 23,970 | -0.8% | 0.48% | +0.6% |
| Q1 2019 | $3,191,000 | +28.0% | 24,170 | 0.0% | 0.47% | +8.5% |
| Q4 2018 | $2,492,000 | -5.1% | 24,170 | 0.0% | 0.44% | +15.7% |
| Q3 2018 | $2,626,000 | +10.1% | 24,170 | 0.0% | 0.38% | +6.2% |
| Q2 2018 | $2,385,000 | +0.8% | 24,170 | 0.0% | 0.35% | -2.5% |
| Q1 2018 | $2,366,000 | +5.5% | 24,170 | 0.0% | 0.36% | +9.3% |
| Q4 2017 | $2,243,000 | +7.5% | 24,170 | -0.6% | 0.33% | +1.8% |
| Q3 2017 | $2,086,000 | +1.7% | 24,320 | 0.0% | 0.33% | -2.4% |
| Q2 2017 | $2,052,000 | -2.6% | 24,320 | -1.2% | 0.33% | -7.0% |
| Q1 2017 | $2,106,000 | +13.0% | 24,620 | +2.8% | 0.36% | +13.2% |
| Q4 2016 | $1,864,000 | -0.7% | 23,950 | 0.0% | 0.32% | -7.3% |
| Q3 2016 | $1,877,000 | -22.4% | 23,950 | 0.0% | 0.34% | -26.0% |
| Q2 2016 | $2,419,000 | +6.0% | 23,950 | -0.4% | 0.46% | +7.4% |
| Q1 2016 | $2,281,000 | +0.8% | 24,050 | -1.2% | 0.43% | -5.3% |
| Q4 2015 | $2,262,000 | +6.4% | 24,350 | -2.4% | 0.45% | +2.0% |
| Q3 2015 | $2,126,000 | -1.8% | 24,950 | -1.4% | 0.44% | +6.0% |
| Q2 2015 | $2,165,000 | +0.8% | 25,300 | 0.0% | 0.42% | -0.5% |
| Q1 2015 | $2,148,000 | -1.7% | 25,300 | -0.8% | 0.42% | +3.2% |
| Q4 2014 | $2,186,000 | +12.9% | 25,500 | 0.0% | 0.41% | +12.1% |
| Q3 2014 | $1,937,000 | -3.5% | 25,500 | 0.0% | 0.36% | -2.1% |
| Q2 2014 | $2,008,000 | +4.6% | 25,500 | -0.4% | 0.37% | -0.5% |
| Q1 2014 | $1,920,000 | -2.8% | 25,600 | 0.0% | 0.38% | -5.8% |
| Q4 2013 | $1,976,000 | +11.3% | 25,600 | 0.0% | 0.40% | +5.3% |
| Q3 2013 | $1,775,000 | +2.7% | 25,600 | -1.9% | 0.38% | -2.3% |
| Q2 2013 | $1,728,000 | – | 26,100 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |